CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 59 enrolled
Drug / intervention
balloon sinus dilation +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01714687
NCT01714687N/ACompleted
CompareCT.gov

Comparison of Balloon Sinuplasty In-Office Versus Medical Management for Recurrent Acute Sinusitis Patients: A Randomized Controlled Study (CABERNET)

Integra LifeSciences Corporation·interventional·Posted Oct 26, 2012·Updated Jul 12, 2024

In Brief

A clinical study evaluating balloon sinus dilation and medical therapy for Recurrent Acute Rhinosinusitis. Completed, enrolled 59 participants across 5 sites.

Detailed Summary

This post-market study aims to compare health outcomes for Recurrent Acute Rhinosinusitis (RARS) patients treated with balloon sinus dilation (BSD) versus medical management alone.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRecurrent Acute Rhinosinusitis
CountriesUnited States
CollaboratorsAcclarent

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedOct 26, 2012
Enrollment StartOct 1, 2012
Primary CompletionOct 1, 2015
Study CompletionApr 1, 2016
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 13.7 years ago

Interventions

balloon sinus dilationdevice

medical therapyother